Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma-Reference-Cited by-同舟云学术

Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma

Published:2023-09-10 Issue:14 Volume:64 Page:2279-2285
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Dahi Parastoo B.¹²^ORCID,Kenny Sheila¹,Flynn Jessica³,Devlin Sean M.³,Ruiz Josel D.¹,Chinapen Stephanie A.¹,Lahoud Oscar B.¹,Matasar Matthew J.⁴,Moskowitz Craig H.⁵,Perales Miguel-Angel¹²,Shah Gunjan¹²,Sauter Craig S.⁶,Giralt Sergio A.¹²^ORCID,Geyer Alexander I.⁷,Jakubowski Ann A.¹²

Affiliation:

1. Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

2. Department of Medicine, Weill Cornell Medical College, New York, NY, USA

3. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

4. Department of Medicine, Rutgers Cancer Institute, New Brunswick, NJ, USA

5. Hematology, University of Miami Health System, Sylvester Comprehensive Cancer Center, Miami, FL, USA

6. Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA

7. Pulmonary Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Funder

National Institutes of Health

National Cancer Institute Cancer Center

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2023.2256912

Reference37 articles.

1. High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

2. Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

3. High-Dose Therapy Improves Progression-Free Survival and Survival in Relapsed Follicular Non-Hodgkin’s Lymphoma: Results From the Randomized European CUP Trial

4. Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01

5. Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma